This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.
Denton has held various leadership roles, including senior vice president and controller/chief accounting officer and has previously worked with the management consulting firm of Deloitte Touche Tohmatsu.
These are among Deloitte’s predictions for life sciences and the future for drugs companies and their operations, from The Future Awakens: Life Sciences and Health Care Predictions 2022 (Deloitte, November
A study published in December by Deloitte showed that R&D costs have doubled in eight years, while peak sales forecasts have halved.
The research by Deloitte’s Centre for Health Solutions found returns had declined 1.8 percentage points from 3.7% in 2017. ... Deloitte says the industry needs to tackle the problem with new ways of working and emphasis on finding the right talent.
According to a Deloitte report, AI ‘can help analyse large data sets from sources such as clinical trials, health records, genetic profiles and preclinical studies; within this data, it can recognise ... Deloitte also suggests AI can help improve study
According to a Deloitte survey, 75% of British companies are now pessimistic about Brexit after weak investment and waning revenues in the most recent financial quarter.
More from news
Approximately 2 fully matching, plus 18 partially matching documents found.
According to the Deloitte Center for Health Solutions, interviews held with technology executives and leaders of healthcare systems evidenced the belief that digital transformation initiatives are mainly consumer-centric, with 92%
The author works within the broader life sciences/risk division of Deloitte in the Netherlands and this article combines the latest opinions and insights from across that team. ... Frits Stulp is managing director of Iperion, a Deloitte business, visit
Reports by analysts Deloitte underscore the value of PSPs as industry pivots to outcomes- based reimbursement models and emphasise the potential from AI, analytics and data.
A recent analysis by Deloitte showed that most new drugs continue with the revenue trajectory set at launch – around 70% of products that miss expectations at launch continue doing so in
According to Deloitte Insight’s 2021 Global Marketing Trends report, purpose is one of the key aspects necessary for businesses to flourish – they need to understand why they exist and who ... According to a 2019/20 Deloitte survey, 68% of biopharma
More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.
Prior to that, she held several senior communications roles, including chief communications officer at Deloitte, as well as senior roles at Novartis, Pfizer and leadership roles at biotech and healthcare communications
Stockdale arrives at the company from e-Therapeutics, where he had been financial controller since 2012, and has also previously served at Deloitte as a senior manager.
Previously healthcare and life sciences partner at Deloitte Consulting, Vogt has experience advising companies in the medtech, healthcare and pharmaceutical industries in implementing and improving strategies. ... Prior to his experience at Deloitte
Prior to this, Souza held the role of chief financial officer at Aetna, overseeing its guaranteed products business, and has also held senior leadership positions at Deloitte and PriceWaterhouseCooper.
He brings 20 years of financial and managerial experience to the role, having worked at Deloitte, Eaga, PriceWaterhouseCoopers and Barclays, where he headed up its North East corporate banking division.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
So prevalent are these issues, that one Deloitte industry study found that more than 57% of surveyed healthcare professionals could recall a time when a physician didn’t have the product ... By Asma Shirazi, Page &Page and Partners.
Advisors. Genesis Research was advised on the transaction by Clearview Healthcare Partners, Deloitte, Palo Alto, Piper Sandler and Ropes &Gray.
Ropes &Gray acted as legal advisor to GHO; CIL as commercial advisor; Alvarez and Marsal as financial advisor; Deloitte LLP as tax advisor and CRS as insurance advisor.
The COVID-19 pandemic has brought into sharp focus the need to harness and leverage digital tools and technology for remote patient monitoring (RPM). With the onset of lockdown, and a sense of unease when visiting conventional clinical settings,
Ladana Edwards, Partner at Deloitte Central Europe and Thomas de Bruyne, Consultant with Deloitte Belgium, share their thoughts on the future of education and the role of digital technologies such as
More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.
No results were found
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....